{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:17:34Z","timestamp":1770970654626,"version":"3.50.1"},"reference-count":85,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T00:00:00Z","timestamp":1229299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Develop Med Child Neuro"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:p>This systematic review of the effects of bisphosphonate treatment in children with osteogenesis imperfecta was conducted using the American Academy for Cerebral Palsy and Developmental Medicine methodology for developing systematic reviews of treatment interventions (Revision 1.1) 2004. Despite a large body of published literature, there have been only eight studies with a sufficiently high level of internal validity to be truly informative. These studies confirm improvement in bone density. Many, but not all studies, demonstrate reduction in fracture rate and enhanced growth. There has been extremely limited evaluation of broader treatment impacts such as deformity, need for orthopedic surgery, pain, functioning, or quality of life. Short\u2010term side effects were minimal. Which medication and dosing regimen is optimal and how long patients should be treated are unclear. This body of evidence would be strengthened by a larger controlled trial, because many studies lacked adequate power to evaluate stated outcomes. These studies do not address the impacts of bisphosphonates in children with milder forms of osteogenesis imperfecta and severe forms that are not due to mutations in the type I pro\u2010collagen gene (e.g. types VII and VIII). Additional research is needed into treatment of infants. More studies evaluating medication choices, optimal dosing, duration of treatment, post\u2010treatment impacts, and long\u2010term side effects are necessary.<\/jats:p>","DOI":"10.1111\/j.1469-8749.2008.03222.x","type":"journal-article","created":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T03:18:24Z","timestamp":1245727104000},"page":"17-29","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review"],"prefix":"10.1111","volume":"51","author":[{"given":"HEIDI","family":"CASTILLO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LISA","family":"SAMSON\u2010FANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ON BEHALF OF THE AMERICAN ACADEMY FOR CEREBRAL PALSY AND DEVELOPMENTAL MEDICINE TREATMENT OUTCOMES COMMITTEE REVIEW PANEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,15]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-4-16"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0217051"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.16.2.101"},{"key":"e_1_2_7_5_2","first-page":"603","article-title":"Osteogenesis imperfecta: perspectives and opportunities","volume":"12","author":"Byers PH","year":"2000","journal-title":"Pediatrics"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1227"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00003086-198109000-00012","article-title":"Systemic treatment of osteogenesis imperfecta","volume":"159","author":"Albright JA","year":"1981","journal-title":"Clin Orthop Relat Res"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00350961"},{"key":"e_1_2_7_9_2","volume-title":"AACPDM methodology for developing evidence tables and reviewing treatment outcome research. Revision 1.1","author":"American Academy of Cerebral Palsy and Developmental Medicine"},{"key":"e_1_2_7_10_2","volume-title":"International Classification of Functioning, Disability and Health (ICF)","year":"2001"},{"key":"e_1_2_7_11_2","volume-title":"Oxford Centre for Evidence\u2010Based Medicine levels of evidence, May 2001","author":"Phillips R"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16101-1"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041232"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050109"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.bpo.0000176162.78980.ed"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.03.013"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2413"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2005.18.1.43"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.051006"},{"key":"e_1_2_7_20_2","volume-title":"Clinical and bone densitometric improvement after pamidronate infusion in children with severe osteogenesis imperfecta","author":"Bishop NJ","year":"1996"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70074-X"},{"key":"e_1_2_7_22_2","first-page":"261","article-title":"Intravenous pamidronate treatment in osteogenesis imperfecta","volume":"157","author":"Fujiwara I","year":"1998","journal-title":"Eur J Pediatr"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.77.1.91c"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1998.tb01388.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810013391402"},{"key":"e_1_2_7_26_2","first-page":"559","article-title":"Osteogenesis imperfecta: are fractures and growth hormone treatment linked","volume":"123","author":"Kodama H","year":"1998","journal-title":"J Pediatr"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.5.1846"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2001.14.5.529"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004310100844"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.6.562-a"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215952"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022099425316"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.3.573"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-003-0865-1"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021371"},{"key":"e_1_2_7_36_2","first-page":"322","article-title":"The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta","volume":"46","author":"Adiyaman P","year":"2004","journal-title":"Turk J Pediatr"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2003.11.019"},{"key":"e_1_2_7_38_2","first-page":"1772","article-title":"Radiological features of bisphosphonate therapy in children with osteogenesis imperfecta","volume":"25","author":"Bin\u2010Abbas BS","year":"2004","journal-title":"Saudi Med J"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2004.07.003"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2004.03.008"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040814"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2004.17.11.1511"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.bpo.0000164871.36098.4c"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2004.08.011"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050213"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.bpo.0000152940.10487.c9"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2054"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.bpb.0000192058.98484.5b"},{"key":"e_1_2_7_49_2","first-page":"124","article-title":"Low\u2010dose intravenous pamidronate treatment in osteogenesis imperfecta","volume":"48","author":"Goksen D","year":"2007","journal-title":"Turk J Pediatr"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.051207"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2006.tb02235.x"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.07.020"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.096552"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2007.22.2.209"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.10.010"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/01241398-198809000-00022"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/01241398-198801000-00017"},{"key":"e_1_2_7_58_2","first-page":"1515","volume-title":"Osteoporosis","author":"Devogelaer JP","year":"1990"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199707000-00005"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050715"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.76.2.169"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.1999.12.4.555"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.86.5.356"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.10.945"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.10.854"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2003.tb00577.x"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.5.e601"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.4.610"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.5.1030"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040303"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2005.00567.x"},{"key":"e_1_2_7_72_2","first-page":"1158","article-title":"Oral alendronate in osteogenesis imperfecta","volume":"42","author":"Unal E","year":"2005","journal-title":"Indian Pediatr"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2004.09.005"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.04.004"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.10.041"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2006.21.4.709"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000208490.22492.09"},{"key":"e_1_2_7_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.bsd.0000208253.06706.42"},{"key":"e_1_2_7_79_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2036"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.02.071"},{"key":"e_1_2_7_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.11.020"},{"key":"e_1_2_7_82_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038103"},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc062792"},{"key":"e_1_2_7_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2006.05.009"},{"key":"e_1_2_7_85_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040711"},{"key":"e_1_2_7_86_2","first-page":"344","article-title":"Maternal and fetal outcome of pamidronate treatment before conception: a case report","volume":"25","author":"Cabar FR","year":"2007","journal-title":"Clin Exp Rheumatol"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.2008.03222.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1469-8749.2008.03222.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T10:45:46Z","timestamp":1697366746000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1469-8749.2008.03222.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,15]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1469-8749.2008.03222.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-8749.2008.03222.x","archive":["Portico"],"relation":{},"ISSN":["0012-1622","1469-8749"],"issn-type":[{"value":"0012-1622","type":"print"},{"value":"1469-8749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,15]]},"assertion":[{"value":"2008-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}